
This Site contains forward-looking statements concerning, among
other things, Northfield’s future business plans and strategies
and clinical and regulatory developments affecting our PolyHeme®
blood substitute product. These forward-looking statements are identified
by the use of such terms as “intends,” “expects,”
“plans,” “estimates,” “anticipates,”
“should,” “believes” and similar terms.
These forward-looking statements involve inherent risks and uncertainties.
Our actual results may therefore differ materially from those predicted
by the forward-looking statements because of various factors and
possible events, including our ability to obtain FDA approval to
market PolyHeme® commercially, the availability of capital to
finance our clinical trials and ongoing business operations, our
ability to obtain adequate supplies of raw materials and to manufacture
PolyHeme® in commercial quantities, our ability to market PolyHeme®
successfully, the possibility that competitors will develop products
that will render PolyHeme® obsolete or non-competitive, our
ability to protect our intellectual property rights, the possibility
that we may be subject to product liability claims and other legal
actions, our dependency on a limited number of key personnel, the
uncertainty of third party reimbursement for our product and other
risks and uncertainties described from time to time in our periodic
reports filed with the Securities and Exchange Commission, including
our most recently filed quarterly report on Form 10-Q and annual
report on Form 10-K. Forward-looking information is current only
at the time it is included on this Site. We do not undertake any
obligation to update or publicly release any revisions to forward-looking
information to reflect events, circumstances or changes in expectations
after the time such information is included on this Site. All subsequent
written and oral forward-looking statements attributable to Northfield
or any person acting on our behalf are qualified by this cautionary
statement.
Back
to Top
|